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Atopic dermatitis (AD) is a chronic dermatosis bearing clinical, histological, and immunologic similarities to
chronic allergic contact dermatitis (ACD). AD shows a Th2 cell-dominant inflammatory infiltrate, elevated serum
IgE levels, a permeability barrier abnormality, and Staphylococcus aureas colonization. Repeated hapten
challenges reportedly produce a Th2-like hypersensitivity reaction (Th2-like HR). Here, 9–10 challenges with
oxazolone (Ox) to hairless mice also produced a chronic Th2-like HR. Permeability barrier function and
expression of differentiation proteins, filaggrin, loricrin, and involucrin, became abnormal. CRTH-positive Th2-
dominant inflammatory infiltrate, with increased IL-4 expression, and a large increase in serum IgE levels were
observed. The barrier abnormality was associated with decreased stratum corneum (SC) ceramide content and
impaired lamellar body secretion, resulting in abnormal lamellar membranes, as in human AD. Furthermore, as
in human AD, epidermal serine protease activity in SC increased and expression of two lamellar body-derived
antimicrobial peptides, CRAMP and mBD3, declined after Ox challenges, paralleling the decrease of their
human homologues in AD. Thus, multiple Ox challenges to normal murine skin produce a chronic Th2-like HR,
with multiple features of human AD. Because of its reproducibility, predictability, and low cost, this model could
prove useful for evaluating both pathogenic mechanisms and potential therapies for AD.
Journal of Investigative Dermatology (2008) 128, 79–86; doi:10.1038/sj.jid.5701011; published online 2 August 2007
INTRODUCTION
Over the last decade, a variety of murine models have been
developed and characterized that display certain features of
atopic dermatitis (AD). These models include: (1) sponta-
neous mutants, such as the Nc/Nga mouse (Matsuda et al.,
1997; Aioi et al., 2001); (2) transgenic mice that either
over- or under-express selective cytokines, such as IL-4,
IL-18, or thymic stromal lymphopoietic factor (Chan et al.,
2001b; Konishi et al., 2002; Chen et al., 2005); (3) mice
genetically-engineered to over-express stratum corneum (SC)
chymotryptic enzyme (kallikrein 7) (Hansson et al., 2002);
and (4) mice challenged repeatedly with applications of
soluble or aerosol haptens, such as ovalbumen (Savinko
et al., 2005), mite antigens (Matsuoka et al., 2003; Gao et al.,
2004; Kang et al., 2006), or trinitrochlorobenzene (Matsu-
moto et al., 2004). While repeated hapten challenges elicit an
AD-like dermatosis with some features of AD (Matsumoto
et al., 2004), an analogous process occurs only rarely in
otherwise normal humans (Werfel et al., 1997), perhaps
because barrier function is superior in human epidermis. The
importance of a primary inherited defect in the barrier, with
subsequent hapten ingress, for the pathogenesis of AD is
becoming increasingly accepted, because inherited muta-
tions in the gene that encodes the SC structural protein,
filaggrin, have been reported in a plurality of European
kindreds with AD (Marenholz et al., 2006; Palmer
et al., 2006; Sandilands et al., 2006; Smith et al., 2006;
Weidinger et al., 2006).
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To date, hapten-induced, chronic ACD models, although
having the unique advantages of being convenient, reproducible,
and inexpensive, have not been sufficiently characterized to
ascertain whether they are true analogues of AD. While the
trinitrochlorobenzene model displays certain clinical and
immunologic features of human AD (Matsumoto et al., 2004;
Matsukura et al., 2005; Tagami and Kikuchi, 2006), whether
epidermal structural, functional, and lipid biochemical ab-
normalities, characteristic of human AD, occur in this model, is
not known. Without these types of essential data, hapten-
induced models remain of limited use for further studies on
either AD pathogenesis, or for the evaluation of barrier-based,
therapeutic interventions of potential utility in AD. We describe
here another hapten-induced chronic Th2-like hypersensitivity
reaction (HR) model, in which simple applications of the
sensitizer, oxazolone (Ox), previously utilized to elicit ACD
(Sheu et al., 2002; Fowler et al., 2003), was utilized to generate
a chronic Th2-like hypersensitivity reaction (Th2-like HR)
model. Following 10 Ox challenges, a dermatosis emerges with
not only the immunologic but also with epidermal structural,
functional, and biochemical abnormalities that parallel human
AD. Availability of this thoroughly characterized model should
facilitate future studies on both AD pathogenesis, as well as the
evaluation of emerging therapies for AD.
RESULTS
Repeated Ox applications provoke a pruritic dermatosis with
increased epidermal hyperplasia and aberrant epidermal
differentiation
While a single Ox challenge to hairless mouse skin produces
an acute ACD-like, erythematous and edematous dermatosis
over 6–12 hours (Figure S1; see also Sheu et al., 2002; Fowler
et al., 2003), 9–10 Ox challenges over 22–25 days provoked a
persistent, chronic dermatosis with evidence of moderate-to-
severe pruritus (Figure S1).
Whereas single Ox challenges produce mild epidermal
hyperplasia, this feature became more prominent with
successive challenges (Figure S2), so that by 10 applications
mean epidermal thickness was 2.0670.05 vs 0.6770.03 in
vehicle-treated controls (Po0.0001). The development of
epidermal hyperplasia could be attributed to a marked
increase in DNA synthesis, demonstrated by increased
numbers of proliferating cell nuclear antigenþ cells in the
basal and first suprabasal epidermal layers (Figure S2).
Finally, epidermal hyperplasia was accompanied by a promi-
nent inflammatory infiltrate, even after one Ox challenge,
but inflammation became more apparent after 10 Ox
challenges (Figure S2). In parallel with the emergence of
epidermal hyperplasia and inflammation, expression of three
structural protein markers of differentiation (loricrin, involu-
crin, filaggrin) either declined in the outer nucleated layers,
or extended proximally into suprabasal cell layers with
repeated Ox challenges (Figure S3).
Abnormal epidermal function appears only after repeated
hapten applications
We next assessed whether progression from acute to chronic
ACD is associated with alterations in epidermal functional
parameters, including changes in permeability barrier
homeostasis, SC hydration, and SC acidification. While all
of these functions remain normal after a single Ox challenge,
basal permeability barrier homeostasis, assessed as rates of
transepidermal water loss (TEWL) increased markedly after 10
Ox challenges (Figure 1c, 410-fold elevation; Po0.0001).
At this time point, SC hydration also declined significantly
(Figure 1a; Po0.01), while skin surface pH increased by
about 12 a unit (Figure 1b; Po0.01). Finally, barrier recovery
kinetics, assessed as the rate of decline in TEWL over time,
either accelerated modestly or remained unchanged in
repeatedly Ox-challenged skin sites (Figure 1d), as in human
AD (Seidenari and Giusti, 1995).
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Figure 1. Functional abnormalities emerge after multiple Ox Challenges.
(a) SC hydration assessed as electrical capacitance, in absolute units.
(b) Surface pH assessed with a flat surface electrode. (c) Permeability barrier
function, assessed as changes in basal TEWL with an electrolytic water
analyzer (as mg/cm2/hour). (d) Kinetics of permeability barrier recovery after
acute barrier disruption by cellophane tape stripping (initial TEWL is
increased to 20- to 30-fold above basal levels).
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SC lipid abnormalities correlate with the barrier abnormality in
Ox-challenged mice
Human AD is characterized by a decline in two key SC lipids,
ceramides (Cers), and free fatty acids, with a further, selective
decline in certain Cer species, most notably Cer 3 (Di Nardo
et al., 1998; Macheleidt et al., 2002). Although total Cer
content of SC in 10 Ox-challenged mice did not reduced,
total free fatty acid content declined and that of cholesterol
increased, as in human AD (Figure 2). Moreover, one of the
five individual Cer species (murine SC displays only five Cer
species because of lesser variation in sphingoid base and
N-acyl fatty acid hydroxylation), Cer 3 declined significantly
versus vehicle-treated controls (Figure 2; Po0.001), as
observed repeatedly in human AD (Di Nardo et al., 1998;
Macheleidt et al., 2002).
Ox-challenged mice display abnormalities in lamellar body
secretion and post-secretory, lamellar membrane organization
The epidermis of human AD displays abnormalities in both
lamellar body secretion (Fartasch et al., 1992) and extra-
cellular lamellar bilayer structure (Chamlin et al., 2002),
findings that correlate with reported lipid abnormalities
(Chamlin et al., 2002). While both lamellar body density
and internal contents appeared normal in repeatedly Ox-
challenged mice, secretion was impaired, as evidenced by
retention of organelles in the peripheral cytosol (Figure 3a),
coupled with reduced secretion at the stratum granulosum
–SC interface (Figure 3c). Since considerable lamellar body
contents become entombed within the corneocyte cytosol
(Figure 3d, open arrows), rather than secreted, these contents
would be unavailable to form lamellar membranes; hence,
the decreased numbers of lamellar bilayers in repeated Ox-
challenged mice (Figure 3d), as in human AD.
Ultrastructural evidence of impaired SC cohesion in
Ox-challenged mice
The desquamation abnormality in repeatedly Ox-challenged
mice could result, in part, from epidermal hyperplasia (Figure
S2), but it also correlated here with multiple foci in the lower
SC where corneocytes appeared to detach prematurely
(Figure 3c). Extensive separation occurred both between
adjacent corneocytes (Figure 3c, asterisks), and between the
SC and the underlying nucleated cell layers (Figure 3c, open
arrows). These ultrastructural findings are consistent with
the visible scale in these mice, increased serine protease
(SP) activity in these mice (see below), and the decreased
SC cohesion in human AD (Cork et al., 2006).
SP activity increases in Ox-challenged mice
The elevation in surface pH that follows repeated Ox
challenges (Figure 1b) could result in increased SP activity
(Hachem et al., 2003, 2005a). Such pH-induced changes in
SP activity could, in turn, account for the abnormal
corneocyte cohesion in Ox-challenged mice through degra-
dation of corneodesmosomes. To assess this potential
pathomechanism, we next assessed changes in SP activity
and localization after Ox challenges by in situ zymography.
SP activity was low both under basal conditions (Figure S4)
and after single Ox challenges (Figure S4), and was restricted
to a narrow region of the SC. In contrast, after 10 Ox
challenges, SP activity increased throughout the SC, further
impinging on the outer nucleated layers (Figure S4). The
increase in SP activity correlates with the observed increase
in pH of SC (c.f., Figure 1), providing a mechanistic basis for
the alterations in desquamation in these mice.
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Figure 2. Repeated Ox challenges alter stratum corneum lipid content/
distribution. Cohorts of hairless mice (n¼ 5 each) were treated with vehicle
alone, or Ox (1 or 10 applications). Lipids were extracted from isolated
stratum corneum sheets with Bligh–Dyer solvents, fractionated, quantified,
and the content of each fraction was expressed as mg/mg dry SC weight. Data
were expressed as % change from vehicle-treated7SEM.
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Figure 3. Repeat Ox-challenged SC displays entombed lamellar bodies,
lamellar membrane disorganization, and corneocyte detachment.
(a) Lamellar bodies (LBs) accumulate in the peripheral cytosol of granular
cells in Ox-challenged mice (arrows), while (b) LB are more widely dispersed
in preparation for secretion in vehicle (Veh)-treated mice. (c) Ox-challenged
corneocytes (SC) focally detach from underlying stratum granulosum (SG) and
lose contact between themselves (open arrows), sometimes leading to large
cleavage planes (asterisk). Decreased quantities and poor organization of
extracellular lamellar membranes are seen in Ox-challenged (d, single
arrows) versus vehicle-treated (e, layered arrows) mice. Note entombed
organelle remnants in corneocyte cytosol of Ox-challenged mice, indicating
incomplete LB secretion (d, open arrows). (a–c) Osmium tetroxide
post-fixation; (d, e) ruthenium tetroxide post-fixation. Bars¼ 1mm (a–c);
0.1mm (d, e).
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Ox-challenged mice develop abnormalities in innate and
adaptive immunity
We next determined whether repeatedly Ox-challenged mice
develop an immunophenotype that is similar to human AD.
After a single Ox challenge, the dermis displayed a modest
inflammatory infiltrate (Figure S2), dominated by postglandin
D receptor (CRTH2)-negative lymphocytes (Figure 4b) and
most became CRTH2 positive (Figure 4c), with an increased
density of mast cells, but few eosinophils (Figure S2). Over
subsequent challenges, the lymphocyte-dominated infiltrate
increased progressively, with some lymphocytes appearing to
invade the overlying epidermis (Figure S2). The density of
eosinophils in the dermis of 10 Ox-challenged mice also
increased significantly (139.04728.13 vs 8.0275.71 in
vehicle-treated, and 29.41718.46 after a single challenge;
Po0.005 for 10 vs 1 challenge). In addition, immunostaining
for IL-4 also markedly increased in the dermis of 10x Ox-
challenged mice (Figure S5). Finally, the increase in Th2
immunophenotype was paralleled by a progressive increase
in serum IgE levels. While mean serum IgE levels were
29.775.7 after one Ox challenge, they increased to
3,4607734 vs 20.273.5 in 10 vehicle-treated mice
(Po0.002; n¼ 5 each). These results show that repeated Ox
challenges yield a predominant Th2 phenotype, prominent
eosinophils, and highly elevated IgE levels, mirroring humans
with ‘‘extrinsic’’ AD.
In addition to the above-described changes in adaptive
immunity, Ox-challenged mice rapidly developed alterations
in antimicrobial peptide expression. While both the cathe-
licidin carboxyfragment, LL-37, and the human b-defensin 2,
hBD2, typically upregulate during inflammation and/or
wound healing (Sorensen et al., 2003; Butmarc et al.,
2004), both of these peptides fail to upregulate in human
AD (Ong et al., 2002b). Hence, we next assessed changes in
expression of the murine analogues of LL-37 and hBD2 (i.e.,
cathelin-related antimicrobial peptide (CRAMP) and mBD3,
respectively) after one vs 10 Ox challenges. Basal protein
levels of both peptides were demonstrable in the outer
nucleated layers in untreated murine epidermis (Figure 5a
and d), but both CRAMP and mBD3 immunostainable
proteins declined markedly after a single Ox challenge
(Figure 5b and e), a decrease that was sustained after 10
Ox challenges (Figure 5c and f). Thus, repeated hapten
challenges induce changes in two innate immunity peptides
that parallel human AD (Ong et al., 2002b).
DISCUSSION
The striking increase in the incidence of atopic disorders,
including AD, observed in recent decades, has been ascribed
to the migration of populations from rural to urban areas,
where lack of early exposure to a variety of microbes
purportedly results in reduced immune tolerance. Although
the ‘‘hygiene hypothesis’’ may have some validity for
mucosal atopy, the increased prevalence of AD in indus-
trialized, urban areas instead results from increased exposure
to indoor aeroallergens, such as dust mites (Sager et al., 1992;
Matsuoka et al., 2003; Kiank et al., 2006), and life-style
changes coupled with frequent bathing, which could further
degrade the barrier (Cork et al., 2006). Moreover, aeroanti-
a
40.00 m 40.00 m 40.00 m
b c
Vehicle 1 challenge 10 challenges
Figure 4. Th2 immunophenotype predominates after repeated Ox
challenges. (a) CRTH2 immunostaining of Th2 lymphocytes is virtually
absent in dermis after (a) vehicle treatment alone or (b) one Ox challenge, but
density of CRTH2-positive cells increases significantly after 10 challenges
(c, arrows). Merged images with propidium iodide secondary staining in
5mm frozen sections. Bar¼ 40 mm.
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Figure 5. Antimicrobial peptide expression declines after one Ox challenge, and remains reduced after 10 challenges. Immunofluorescent staining for
(a–c) cathelicidin-related antimicrobial peptide (CRAMP) and (d–f) mouse b-defensin 3 (mBD3). (a, d) With vehicle treatment; (b, e) with one Ox challenge;
(c, f) with 10 Ox challenges. Propidium iodide counterstaining. Bars¼ 20mm.
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gens, responsible for mucosal atopy, can also gain access
across the (defective) skin barrier in AD (Sager et al., 1992).
Furthermore, early and frequent use of topical glucocorti-
coids, as well as increased psychologic stress, which
increases endogenous GC, may further degrade the barrier
(Denda and Tsuchiya, 2000; Kao et al., 2003; Choi et al.,
2005a, 2006), thereby increasing disease susceptibility.
Until recently, research on the etiopathogenesis of AD has
focused primarily on immunologic abnormalities, including
the potential provocative role of sensitized dendritic cells
(reviewed in Novak and Bieber (2005), increased IgE
production and/or receptor expression (Boguniewicz et al.,
2006), as well as the Th2 immunophenotype (Grewe et al.,
1998; Leung et al., 2003, 2004), accompanied by production
of cytokines that favor allergic responses and secondary
pathogen colonization (Homey et al., 2006). Without
discounting the role of immunologic influences in the
development of AD, evidence is accumulating that the
primary abnormality in AD could result from inherited
defects in SC structure and function (reviewed in Segre
(2006). Inherited barrier abnormalities may predispose to AD
by facilitating antigen egress. Hence, the focus has shifted,
quite appropriately, from a primarily immunologic (‘‘inside-
outside’’) to a more-probable, ‘‘outside-inside’’ paradigm for
AD pathogenesis (eg, Elias et al., 1996, 1996a, 1996b, 1999;
Elias and Feingold, 1999). Accordingly, it becomes increas-
ingly important to identify and characterize animal models
that allow further investigations into the role of immunologic
and skin barrier abnormalities in AD pathogenesis (Table S1).
The best-characterized murine model, the Nc/Nga mouse,
develops a full panoply of atopic features, including a
permeability barrier abnormality linked to Cer deficiency
(Aioi et al., 2001). AD-like disease only develops when mice
are housed under conventional, ambient (i.e., ‘‘dirty’’), rather
than sun protection factor conditions, but both environmental
and topical haptens can provoke chronic Th2-like HR, even
when Nc/Nga mice are housed in a sun protection factor
facility (Matsuoka et al., 2003; Gao et al., 2004; Kang et al.,
2006). Although the specific abnormality in Nc/Nga mice
remains unknown, they display mutations on chromosome 9,
linked to increased IgE production, as well as Th2-type
T cells, bearing CCR-4, within chronic Th2-like HR lesions
(Matsuoka et al., 2003; Gao et al., 2004; Kang et al., 2006).
Coupled with further disadvantages of high costs, special
housing requirements, and undependable elicitation of skin
lesions, these mice have distinct disadvantages as an AD
model. Likewise, published transgenic models, such as Klk7
(Brattsand and Egelrud, 1999) and IL-4 (Chan et al., 2001a, b)
overexpressing, and IL-18 transgenic mice (Konishi et al.,
2002), while potentially useful for dissecting specific
etiopathogenic steps, are of limited use for assessing alternate
therapeutic approaches for AD, and none of these 3 models is
commercially-available.
Prompted by the urgent need to develop a convenient,
reproducible model, relevant for studies on both AD
pathogenesis and assessment of alternate therapeutic ap-
proaches, we turned to a hapten-induced model, already
employed to assess pathogenesis and potential therapies of
acute allergic contact dermatitis (AACD), the Ox-sensitized
mouse (Nakae et al., 2001; Sheu et al., 2002; Fowler et al.,
2003). We show here that with repeated hapten challenges
over a 2- to 3-week period, this model shifts from typical
delayed-type hypersensitivity, into a more chronic dermato-
sis, with multiple features of AD (Table S1), including the
characteristic barrier (Seidenari and Giusti, 1995) and lipid
abnormalities (Imokawa et al., 1991; Bleck et al., 1999).The
short time required for disease induction, low costs, and
reproducibility of disease expression are yet additional
advantages of this model. Both the timing of disease
development, and the cutaneous features of our model, are
strikingly similar to the dermatosis that follows repeated
applications of trinitrochlorobenzene (Kitagaki et al., 1995;
Matsukura et al., 2005). Although such trinitrochlorobenzene
mice demonstrate a shift from a Th1 to Th2 immunopheno-
type at sites of hapten application, neither epidermal
structure, function, nor lipid biochemistry have been assessed
in this model. Our studies show that initial hapten challenge,
sufficient to elicit AACD, occurs while key epidermal
functions still remain normal, emphasizing that inflammation
alone does not suffice to produce epidermal functional
abnormalities. Further hapten challenges, however, skew the
AACD to a chronic ACD dermatosis, with a full panoply of
features of AD, accompanied by the development of
significant barrier dysfunction, likely allowing still more
allergen to traverse the SC. The lesser competence of the
permeability barrier in AD skin likewise presumably accounts
for hapten ingress, sufficient to skew ACD toward chronic
ACD, with features of AD. Although these results further
underscore the potential importance of inherited abnor-
malities of the SC structural protein, filaggrin (Palmer et al.,
2006), and/or SP/anti-protease polymorphisms (Walley et al.,
2001; Vasilopoulos et al., 2004) as primary provocateurs of
AD, repeated hapten challenge can lead to Th2 cell
activation, which could also reduce barrier function (Hatano
et al., 2005), linking immunologic changes to skin barrier
abnormalities.
MATERIALS AND METHODS
Materials
Female hairless mice (hr/hr), aged 6–8 weeks old, were purchased
from Charles River laboratories (Wilmington, MA) and fed mouse
diet (Ralston-Purina Co., St Louis, MO) and water ad libitum. Ethanol
and petroleum ether were purchased from Fisher Scientific (Fairlane,
NJ). Ox, EDTA and trypsin were purchased from Sigma Chemical
Co. (St Louis, MO). Affinity-purified, rabbit anti-mouse antibodies to
loricrin, involucrin, and filaggrin were purchased from BabCo
(Richmond, CA), and rabbit anti-mouse antibody against the
postglandin D receptor, CRTH2/DP2, was from Cayman Chemical
(Ann Arbor, MI). CRAMP antibody was a gift from Dr Richard Gallo,
UCSD, and the mBD3 antibody was from Alpha Diagnostic (San
Antonio, TX). Biotinylated goat anti-rabbit IgG antibody was
purchased from Vector Lab (Burlingame, CA).
Experimental protocols and functional studies
All animal procedures were approved by the Animal Studies
Subcommittee of the San Francisco Veterans Administration Medical
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Center and performed in accordance with their guidelines. One
group of animals was sensitized by one topical treatment with 10 ml
of 5% Ox, while the ethanol-treated vehicle group served as the
control. A week later, the Ox-treated group was treated topically
with 60 ml of 0.1% Ox on both flanks, once every other day for an
additional 2 weeks, with ethanol alone serving again as vehicle
control. Both before challenge and at the end of the treatment
period, basal TEWL, measured with an electrolytic water analyzer
(Meeco, Warrington, PA), and SC hydration, assessed as capaci-
tance, with a Corneometer CM820 (Courage & Khazaka, Germany),
as described previously (Choi et al., 2005b).
Immunohistochemistry and immunofluorescence
Immunohistochemical staining for assessment of changes in
epidermal differentiation was performed as described earlier
(Demerjian et al., 2006). Briefly, 5mm paraffin sections were
incubated with the primary antibodies overnight at 41C. After
washes  3, sections were incubated with the secondary antibody
for 30 minutes. Staining was detected with ABC-peroxidase kit from
Vector Lab, and sections were then counterstained with hematox-
ylin. For immunohistochemistry for proliferating cells, changes in
overall morphology were visualized after hematoxylin and eosin
staining of 5 mm paraffin-enabled sections, and proliferating cells
were detected by proliferating cell nuclear antigen staining. Briefly,
5mm paraffin sections were incubated with biotinylated monoclonal
antibody against proliferating cell nuclear antigen (CalTag Labora-
tories, Burlingame, CA) overnight at 41C, and staining was detected
by the ABC-peroxidase method (Vector).
Immunofluorescence was used to evaluate changes in T helper
cell subpopulation expression. 5 mm frozen were incubated with the
rabbit anti-mouse CRTH2/DP2 antibody overnight at 41C, followed
by incubation with fluorescence conjugated goat anti-rabbit anti-
body for 30 minutes at room temperature. Both CRAMP and mBD3
protein levels were assessed to determine whether antimicrobial
peptide expression changes in epidermis, as described for human
AD (Ong et al., 2002a, b). For immunohistochemical staining for
IL-4, we employed the method of Fan et al. (2001). Sections were
examined with either a Zeiss fluorescence microscope (Jena,
Germany), or on a confocal microscope, and digital images were
captured with AxioVision software (Carl Zeiss Vision, Munich,
Germany).
Eosinophil density measurement
The areas of dermis in hematoxylin and eosin-stained sections first
were quantitated in a digital microscope equipped with AxioVision
software. The depth of the measured areas extended toE170mm below
the basement membrane. The density of eosinophils was then expressed
as the number of eosinophil per mm2 (n¼ 15 for 10 challenged,
n¼ 12 for single challenge, and n¼ 11 for vehicle-treated samples).
SP activity
SP activity was assessed in freshly obtained skin samples by in situ
zymography, as previously described (Hachem et al., 2003, 2005b).
5mm frozen sections were incubated with BODIPY-FI0-casain for
2 hours at 371C. After 3x washing with 1% Tween 20 solution,
sections were counter-stained with propidium iodide for 1 minute.
Sections then were examined with the Zeiss or confocal micro-
scopes, as above.
Serum IgE measurements
Blood samples were collected from mice tails after one Ox
challenge, 10 Ox challenges, as well as in controls after one and
10 vehicle treatments alone. Serum IgE concentration was deter-
mined with a mouse IgE ELISA quantitation kit from Bethyl
Laboratories (Montgomery, TX), following instructions provided by
the manufacturer.
SC lipid content
After 2 weeks of treatment with Ox or vehicle, fresh SC sheets were
collected after separation of dermis and epidermis by 10 mM EDTA
preincubations, followed by trypsinization, as described (Mao-Qiang
et al., 1996). SC lipids were extracted by Bligh–Dyer solvents, and
quantitated both as total lipids per mg protein and mg dry SC weight.
Lipid extracts were further fractionated into cholesterol, free fatty
acid, and Cer subfractions by high-performance thin layer chroma-
tography, as described previously (Uchida and Hamanaka, 2006).
Electron microscopy
Skin biopsies of both vehicle and Ox-treated mice were fixed in
Karnovsky’s fixative overnight, and post-fixed with either 0.25%
ruthenium tetroxide or 1% aqueous osmium tetroxide, containing
1.5% potassium ferrocyanide, as described previously (Hou et al.,
1991). Ultrathin sections were examined using an electron micro-
scope (Zeiss 10A, Carl Zeiss, Thornwood, NY) operated at 60 kV.
Data are expressed as means7 SEM. A two-tailed Student’s t-test
was used to determine significant differences, and a further analysis
of variance analysis was performed when three or more groups were
compared.
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SUPPLEMENTARY MATERIAL
Table S1. Described pathophysiological features of human AD and AD model
mice.
Figure S1. Repeatedly Ox-challenged mice develop a pruritic dermatosis.
Figure S2. Repeatedly Ox challenges cause epidermal hyperplasia and
chronic inflammation.
Figure S3. Alterations in epidermal differentiation after multiple Ox
challenges.
Figure S4. SP activity increases and extends into nucleated layers after 10 Ox
challenges.
Figure S5. IL-4 increase levels in repeatedly Ox-challenged mice.
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